Back
ProShares UltraShort Dow30 Vs. Sarepta Therapeutics Industry Stock Comparison
Buy
57
DXD
ProShares UltraShort Dow30
Last Price:
$26.09
Seasonality Move:
-5.58%
Sell
38
SRPT
Sarepta Therapeutics
Last Price:
$105.55
Seasonality Move:
5.14%
Buy
57
ProShares UltraShort Dow30 (DXD)
is a Buy
Is ProShares UltraShort Dow30 a Buy, Sell or Hold?
-
The current ProShares UltraShort Dow30 [DXD] share price is $26.08. The Score for DXD is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
-
DXD is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
38
Sarepta Therapeutics (SRPT)
is a Sell
Is Sarepta Therapeutics a Buy, Sell or Hold?
-
The current Sarepta Therapeutics [SRPT] share price is $106.12. The Score for SRPT is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
-
SRPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
DXD Stock Price Chart
What is ProShares UltraShort Dow30's stock price today?
-
The ProShares UltraShort Dow30 share price today is $26.08Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DXD is experiencing slight buying pressure.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $106.12Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.
DXD Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.03 | Sell |
Relative Strength Index (14 RSI): | 60.73 | Buy |
Chaikin Money Flow: | 395296 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (24.47 - 25.41) | Buy |
Bollinger Bands (100): | (24.94 - 27.24) | Sell |
SRPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -3.32 | Sell |
Relative Strength Index (14 RSI): | 35.13 | Sell |
Chaikin Money Flow: | -665542 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (109.06 - 117.26) | Sell |
Bollinger Bands (100): | (113.14 - 127.52) | Sell |
DXD Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 25.19 | Buy |
20-day SMA: | 24.88 | Buy |
50-day SMA: | 25.77 | Buy |
200-day SMA: | 28.47 | Sell |
8-day EMA: | 25.37 | Buy |
20-day EMA: | 25.21 | Buy |
50-day EMA: | 25.57 | Buy |
200-day EMA: | 28.36 | Sell |
SRPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 107.99 | Sell |
20-day SMA: | 112.1 | Sell |
50-day SMA: | 118.2 | Sell |
200-day SMA: | 128.11 | Sell |
8-day EMA: | 108.31 | Sell |
20-day EMA: | 111.56 | Sell |
50-day EMA: | 116.18 | Sell |
200-day EMA: | 122.74 | Sell |
ProShares UltraShort Dow30 Earnings Growth & DXD Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $2.70 per share, a decrease next quarter of $0.00 per share, an increase this year of $7.63 per share, and an increase next year of $4.84 per share.
ProShares UltraShort Dow30 Technical Analysis
Feb 10 | Feb 11 | Feb 12 | Feb 13 | Feb 14 | Feb 18 | Feb 19 | Feb 20 | Feb 21 | Feb 24 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | ||||||||||
10 | 11 | 12 | 13 | 14 | 18 | 19 | 20 | 21 | 24 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Sarepta Therapeutics Technical Analysis
Feb 7 | Feb 10 | Feb 11 | Feb 12 | Feb 13 | Feb 14 | Feb 18 | Feb 19 | Feb 20 | Feb 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | ||||||||||
07 | 10 | 11 | 12 | 13 | 14 | 18 | 19 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |